参考文献[1]
RothGA, MensahGA, JohnsonCO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study[J]. J Am Coll Cardiol, 2020,76(25): 2982-3021. .
[2]
中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2020概要[J].中国循环杂志,2021, 36(6): 521-545. .
[3]
IacobellisG, RibaudoMC, AssaelF, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk[J]. J Clin Endocrinol Metab, 2003, 88(11):5163-5168. .
[4]
IacobellisG, CorradiD, SharmaAM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart[J]. Nat Clin Pract Cardiovasc Med, 2005, 2(10): 536-543. .
[5]
McAninchEA, FonsecaTL, PoggioliR, et al. Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease[J]. Obesity (Silver Spring), 2015, 23(6):1267-1278. .
[6]
IacobellisG. Epicardial fat: a new cardiovascular therapeutic target[J]. Curr Opin Pharmacol, 2016, 27: 13-18. .
[7]
MontiCB, CodariM, De CeccoCN, et al. Novel imaging biomarkers: epicardial adipose tissue evaluation[J]. Br J Radiol, 2020, 93(1113): 20190770. .
[8]
CorradiD, MaestriR, CallegariS, et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts[J]. Cardiovasc Pathol, 2004, 13(6):313-316. .
[9]
SacksHS, FainJN, BahouthSW, et al. Adult epicardial fat exhibits beige features[J]. J Clin Endocrinol Metab, 2013, 98(9):E1448-E1455. .
[10]
MarchingtonJM, PondCM. Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro[J]. Int J Obes, 1990,14(12):1013-1022.
[11]
VuralB, AtalarF, CiftciC, et al. Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome[J]. Cardiovasc Pathol, 2008,17(6):392-398. .
[12]
IacobellisG, di GioiaCR, CotestaD, et al. Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels[J]. Horm Metab Res, 2009,41(3):227-231. .
[13]
IacobellisG, BarbaroG. The double role of epicardial adipose tissue as pro-and anti-inflammatory organ[J]. Horm Metab Res, 2008, 40(7): 442-445. .
[14]
FainbergHP, BirtwistleM, AlagalR, et al. Transcriptional analysis of adipose tissue during development reveals depot-specific responsiveness to maternal dietary supplementation[J]. Sci Rep, 2018,8(1):9628. .
[15]
Villasante FrickeAC, IacobellisG. Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk[J]. Int J Mol Sci, 2019,20(23): 5989. .
[16]
SinghSP, McClungJA, ThompsonE, et al. Cardioprotective heme oxygenase-1-PGC1α signaling in epicardial fat attenuates cardiovascular risk in humans as in obese mice[J]. Obesity (Silver Spring), 2019, 27(10): 1634-1643. .
[17]
IacobellisG, WillensHJ. Echocardiographic epicardial fat: a review of research and clinical applications[J]. J Am Soc Echocardiogr, 2009, 22(12): 1311-1319, 1417-1418. .
[18]
SpearmanJV, RenkerM, SchoepfUJ, et al. Prognostic value of epicardial fat volume measurements by computed tomography: a systematic review of the literature[J]. Eur Radiol, 2015, 25(11): 3372-3381. .
[19]
NelsonAJ, WorthleyMI, PsaltisPJ, et al. Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume[J]. J Cardiovasc Magn Reson, 2009,11: 15. .
[20]
WongCX, GanesanAN, SelvanayagamJB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions[J]. Eur Heart J, 2017,38(17):1294-1302. .
[21]
AntonopoulosAS, SannaF, SabharwalN, et al. Detecting human coronary inflammation by imaging perivascular fat[J]. Sci Transl Med, 2017, 9(398): eaal2658. .
[22]
WenD, AnR, LinS, et al. Influence of different segmentations on the diagnostic performance of pericoronary adipose tissue[J]. Front Cardiovasc Med, 2022, 9: 773524. .
[23]
GrecoF, SalgadoR, Van HeckeW, et al. Epicardial and pericardial fat analysis on CT images and artificial intelligence: a literature review[J]. Quant Imaging Med Surg, 2022,12(3):2075-2089. .
[24]
LibbyP. Inflammation in atherosclerosis-no longer a theory[J]. Clin Chem, 2021,67(1):131-142. .
[25]
HirataY, TabataM, KurobeH, et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue[J]. J Am Coll Cardiol, 2011, 58(3): 248-255. .
[26]
EirasS, Teijeira-FernándezE, ShamagianLG, et al. Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue[J]. Cytokine, 2008, 43(2): 174-180. .
[27]
IacobellisG, PistilliD, GucciardoM, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease[J]. Cytokine, 2005,29(6):251-255. .
[28]
IacobellisG, MalavazosAE, CorsiMM. Epicardial fat: from the biomolecular aspects to the clinical practice[J]. Int J Biochem Cell Biol, 2011,43(12):1651-1654. .
[29]
MazurekT, ZhangL, ZalewskiA, et al. Human epicardial adipose tissue is a source of inflammatory mediators[J]. Circulation, 2003, 108(20): 2460-2466. .
[30]
WangCP, HsuHL, HungWC, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis[J]. Clin Endocrinol (Oxf), 2009, 70(6):876-882. .
[31]
RositoGA, MassaroJM, HoffmannU, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study[J]. Circulation, 2008, 117(5): 605-613. .
[32]
MahabadiAA, LehmannN, KälschH, et al. Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf recall study[J]. JACC Cardiovasc Imaging, 2014, 7(9): 909-916. .
[33]
GorterPM, de VosAM, van der GraafY, et al. Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography[J]. Am J Cardiol, 2008, 102(4): 380-385. .
[34]
MancioJ, PinheiroM, FerreiraW, et al. Gender differences in the association of epicardial adipose tissue and coronary artery calcification: EPICHEART study: EAT and coronary calcification by gender[J]. Int J Cardiol, 2017, 249: 419-425. .
[35]
de VosAM, ProkopM, RoosCJ, et al. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women[J]. Eur Heart J, 2008, 29(6): 777-783. .
[36]
MaR, van AssenM, TiesD, et al. Focal pericoronary adipose tissue attenuation is related to plaque presence, plaque type, and stenosis severity in coronary CTA[J]. Eur Radiol, 2021,31(10):7251-7261. .
[37]
YamashitaK, YamamotoMH, IgawaW, et al. Association of epicardial adipose tissue volume and total coronary plaque burden in patients with coronary artery disease[J]. Int Heart J, 2018,59(6):1219-1226. .
[38]
NakanishiK, FukudaS, TanakaA, et al. Persistent epicardial adipose tissue accumulation is associated with coronary plaque vulnerability and future acute coronary syndrome in non-obese subjects with coronary artery disease[J]. Atherosclerosis, 2014, 237(1): 353-360. .
[39]
HassanM, SaidK, RizkH, et al. Segmental peri-coronary epicardial adipose tissue volume and coronary plaque characteristics[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(10):1169-1177. .
[40]
SunY, LiXG, XuK, et al. Relationship between epicardial fat volume on cardiac CT and atherosclerosis severity in three-vessel coronary artery disease: a single-center cross-sectional study[J]. BMC Cardiovasc Disord, 2022, 22(1):76. .
[41]
MahabadiAA, BalcerB, DykunI, et al. Cardiac computed tomography-derived epicardial fat volume and attenuation independently distinguish patients with and without myocardial infarction[J]. PLoS One, 2017, 12(8): e0183514. .
[42]
DingJ, HsuFC, HarrisTB, et al. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA)[J]. Am J Clin Nutr, 2009,90(3):499-504. .
[43]
MahabadiAA, BergMH, LehmannN, et al. Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study[J]. J Am Coll Cardiol, 2013, 61(13): 1388-1395. .
[44]
OikonomouEK, MarwanM, DesaiMY, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data[J]. Lancet, 2018, 392(10151): 929-939. .
[45]
PasqualettoMC, TuttolomondoD, CutruzzolàA, et al. Human coronary inflammation by computed tomography: Relationship with coronary microvascular dysfunction[J]. Int J Cardiol, 2021,336:8-13. .
[46]
KataokaT, HaradaK, TanakaA, et al. Relationship between epicardial adipose tissue volume and coronary artery spasm[J]. Int J Cardiol, 2021, 324: 8-12. .
[47]
HuangS, LiY, JiangL, et al. Impact of type 2 diabetes mellitus on epicardial adipose tissue and myocardial microcirculation by MRI in postmenopausal women[J]. J Magn Reson Imaging, 2022,.
[48]
MagnaniJW, RienstraM, LinH, et al. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics[J]. Circulation, 2011, 124(18): 1982-1993. .
[49]
IacobellisG, WillensHJ, BarbaroG, et al. Threshold values of high-risk echocardiographic epicardial fat thickness[J]. Obesity (Silver Spring), 2008,16(4):887-892. .
[50]
MazurekT, KiliszekM, KobyleckaM, et al. Relation of proinflammatory activity of epicardial adipose tissue to the occurrence of atrial fibrillation[J]. Am J Cardiol, 2014,113(9): 1505-1508. .
[51]
ZhouM, WangH, ChenJ, et al. Epicardial adipose tissue and atrial fibrillation: Possible mechanisms, potential therapies, and future directions[J]. Pacing Clin Electrophysiol, 2020,43(1):133-145. .
[52]
ThanassoulisG, MassaroJM, O′DonnellCJ, et al. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study[J]. Circ Arrhythm Electrophysiol, 2010,3(4):345-350. .
[53]
JhuoSJ, HsiehTJ, TangWH, et al. The association of the amounts of epicardial fat, P wave duration, and PR interval in electrocardiogram[J]. J Electrocardiol, 2018, 51(4): 645-651. .
[54]
MasudaM, MizunoH, EnchiY, et al. Abundant epicardial adipose tissue surrounding the left atrium predicts early rather than late recurrence of atrial fibrillation after catheter ablation[J]. J Interv Card Electrophysiol, 2015, 44(1): 31-37. .
[55]
WongCX, AbedHS, MolaeeP, et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome[J]. J Am Coll Cardiol, 2011, 57(17): 1745-1751. .
[56]
YangM, CaoQ, XuZ, et al. Development and validation of a machine learning-based radiomics model on cardiac computed tomography of epicardial adipose tissue in predicting characteristics and recurrence of atrial fibrillation[J]. Front Cardiovasc Med, 2022, 9: 813085. .
[57]
YangM, BaoW, XuZ, et al. Association between epicardial adipose tissue and recurrence of atrial fibrillation after ablation: a propensity score-matched analysis[J]. Int J Cardiovasc Imaging, 2022[]. .
[58]
YancyCW, JessupM, BozkurtB, et al. 2017 ACC /AHA /HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology /American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America[J]. J Am Coll Cardiol, 2017, 70(6): 776-803. .
[59]
ObokataM, ReddyY, PislaruSV, et al. Evidence Supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction[J]. Circulation, 2017,136(1): 6-19. .
[60]
van WoerdenG, GorterTM, WestenbrinkBD, et al. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction[J]. Eur J Heart Fail, 2018, 20(11): 1559-1566. .
[61]
DoeschC, StreitnerF, BellmS, et al. Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy[J]. Obesity (Silver Spring), 2013, 21(3): E253-E261. .
[62]
WangX, ButcherSC, KunemanJH, et al. The quantity of epicardial adipose tissue in patients having ablation for atrial fibrillation with and without heart failure[J]. Am J Cardiol, 2022, 118(3): 625-633. .
[63]
CorreiaE, BarbettaL, CostaO, et al. Epicardial adipose tissue in heart failure phenotypes-a meta-analysis[J]. Arq Bras Cardiol, 2022, 118(3): 625-633. .
[64]
PuglieseNR, PaneniF, MazzolaM, et al. Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure[J]. Eur J Heart Fail, 2021,23(11):1858-1871. .
[65]
van WoerdenG, van VeldhuisenDJ, ManintveldOC, et al. Epicardial adipose tissue and outcome in heart failure with mid-range and preserved ejection fraction[J]. Circ Heart Fail, 2022,15(3):e009238. .
[66]
NyawoTA, DludlaPV, Mazibuko-MbejeSE, et al. A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at risk of heart failure[J]. Heart Fail Rev, 2022,27(2):665-675. .
[67]
MassonW, Lavalle-CoboA, NogueiraJP. Effect of SGLT2-inhibitors on epicardial adipose tissue: a meta-analysis[J]. Cells, 2021, 10(8): 2150. .
[68]
IacobellisG, MohseniM, BiancoSD, et al. Liraglutide causes large and rapid epicardial fat reduction[J]. Obesity (Silver Spring), 2017, 25(2): 311-316. .
[69]
DutourA, AbdesselamI, AncelP, et al. Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy[J]. Diabetes Obes Metab, 2016, 18(9): 882-891. .
[70]
ZiyrekM, KahramanS, OzdemirE, et al. Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients[J]. Rev Port Cardiol (Engl Ed), 2019,38(6):419-423. .
[71]
RaggiP, GadiyaramV, ZhangC, et al. Statins reduce epicardial adipose tissue attenuation independent of lipid lowering: a potential pleiotropic effect[J]. J Am Heart Assoc, 2019,8(12):e013104. .
[72]
RidkerPM, MacFadyenJG, EverettBM, et al. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial[J]. Lancet, 2018, 391(10118): 319-328. .
[73]
MichaR, ImamuraF, Wyler von BallmoosM, et al. Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease[J]. Am J Cardiol, 2011,108(9): 1362-1370. .
[74]
NidorfSM, FioletA, MosterdA, et al. Colchicine in patients with chronic coronary disease[J]. N Engl J Med, 2020, 383(19):1838-1847. .